Document Detail

Assessment of novel combinations of biomarkers for the detection of colorectal cancer.
MedLine Citation:
PMID:  21263188     Owner:  NLM     Status:  In-Data-Review    
Background: Patients with colorectal cancer often present with advanced disease and concomitant poor prognosis. The best known serum biomarker, carcinoembryonic antigen (CEA) is not recommended for screening because of its limited specificity and sensitivity. A number of other circulating proteins have been suggested to be diagnostically useful but individually none of these has proved to be of sufficient sensitivity or specificity to establish a role in routine clinical practice. Here, we test the hypothesis that combining several of these biomarkers will improve diagnostic efficacy. Methods: To select the markers for our model we screened CEA and 26 other candidate biomarkers. Four candidates were selected and their concentrations determined in the serum of 239 patients (106 colorectal cancer patients and 133 non-cancer subjects). Results: Class prediction models based on CEA, DR-70 and sCD26 produced a modest increase in detection accuracy over CEA alone, particularly for early stage cancers. The sensitivity and specificity required for a clinically useful test was not reached. Conclusion: It is unlikely that a biomarker panel comprised of the currently available serum markers will generate a clinically useful diagnostic test for colorectal cancer. Our findings reiterate the urgent need to discover novel biomarkers for the detection of colorectal cancer.
Neil J Shimwell; Wenbin Wei; Sue Wilson; Michael J O Wakelam; Tariq Ismail; Tariq Iqbal; Philip J Johnson; Ashley Martin; Douglas G Ward
Related Documents :
24788058 - Potential of decursin to inhibit the human cytochrome p450 2j2 isoform.
24689438 - Improved in vitro efficacy of gold nanoconstructs by increased loading of g-quadruplex ...
23223548 - Organometallic anticancer agents that interfere with cellular energy processes: a subtl...
17340628 - Anti-proliferative effects of evodiamine on human prostate cancer cell lines du145 and ...
1388248 - Endocrine status in stage ii vs. advanced premenopausal and postmenopausal breast cance...
23370208 - Differences in cancer awareness and beliefs between australia, canada, denmark, norway,...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Cancer biomarkers : section A of Disease markers     Volume:  7     ISSN:  1875-8592     ISO Abbreviation:  Cancer Biomark     Publication Date:  2010 Jan 
Date Detail:
Created Date:  2011-01-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101256509     Medline TA:  Cancer Biomark     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  123-32     Citation Subset:  IM    
School of Cancer Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Association of LEP and ADIPOQ common variants with colorectal cancer in Mexican patients.
Next Document:  Stepwise algorithm combining HPV high-risk DNA-based assays and RNA-based assay for high grade CIN i...